trimebutine has been researched along with duloxetine hydrochloride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Appel, D; Congiu, L; Hermans-Borgmeyer, I; Kleene, R; Loers, G; Lutz, D; Schachner, M; Schäfer, MKE | 1 |
Dbar, SR; Degterev, DA; Diukova, GM; Indejkina, LK; Makarova, AA; Parfenov, AI; Romashkina, NV; Ruchkina, IN | 1 |
1 trial(s) available for trimebutine and duloxetine hydrochloride
Article | Year |
---|---|
[Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
Topics: Adult; Diarrhea; Duloxetine Hydrochloride; Female; Humans; Irritable Bowel Syndrome; Male; Pain; Serotonin and Noradrenaline Reuptake Inhibitors; Trimebutine | 2022 |
1 other study(ies) available for trimebutine and duloxetine hydrochloride
Article | Year |
---|---|
Amelioration of the abnormal phenotype of a new L1 syndrome mouse mutation with L1 mimetics.
Topics: Animals; Cells, Cultured; Cerebellum; Cerebral Ventricles; Corpus Callosum; Duloxetine Hydrochloride; Genetic Diseases, X-Linked; Intellectual Disability; Locomotion; Male; Mice; Mice, Inbred C57BL; Mutation; Neural Cell Adhesion Molecule L1; Neurogenesis; Neurons; Peptidomimetics; Phenotype; Spastic Paraplegia, Hereditary; Toluidines; Trimebutine | 2021 |